This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Carrie Elliott: Innovator in Anti-CTLA-4 Antibody Compositions
Introduction
Carrie Elliott is a prominent inventor based in Seattle, WA, known for her groundbreaking work in the field of biotechnology. She has made significant contributions to the development of anti-CTLA-4 antibody compositions, which have important implications for treating various neoplasia conditions.
Latest Patents
Carrie Elliott holds 1 patent for her invention titled "Anti-CTLA-4 antibody compositions." This patent provides novel compositions of anti-CTLA-4 antibodies that include a chelating agent. The invention also outlines methods for treating diseases and conditions using these innovative antibody compositions.
Career Highlights
Carrie is currently employed at Pfizer Corporation, where she continues to advance her research and development efforts in the field of immunotherapy. Her work is pivotal in the ongoing fight against cancer and other serious diseases.
Collaborations
Throughout her career, Carrie has collaborated with notable colleagues, including Justin Abate and Kevin Muthurania. These partnerships have fostered a dynamic research environment that encourages innovation and the sharing of ideas.
Conclusion
Carrie Elliott's contributions to the field of biotechnology, particularly in the development of anti-CTLA-4 antibody compositions, highlight her role as a leading inventor. Her work at Pfizer Corporation and collaborations with esteemed colleagues further underscore her impact on medical research and treatment advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile